Sydney

COVID-19 Vaccine: Australia’s new COVID vaccine, Novavax gets green light from Therapeutic Goods Department | Newcastle Herald

coronavirus,

The fourth type of COVID-19 vaccine has been approved for use in Australia and has been approved by Australian medical regulators for the Novavax vaccine. It will be the same day that the Therapeutic Goods Department has approved the use of two oral COVID-19 treatments. Case of Hunter Covid: Three men in Lake Macquarie died of COVID-19. The government has ordered 51 million doses of vaccine, but final approval from Australia’s leading vaccine advisory group is still pending. More than 95% of the population over the age of 16 receive the first dose of the vaccine, but the head of TGA John Skerritt said Novavax complements existing vaccines such as Pfizer and Modana. “There are people waiting for Novavax, despite the large scale of vaccination in this country, but the final approval is great,” said Professor Skerritt. “Our dream is that we may change our 95 percent to 97 or 98 percent in this country.” Meanwhile, regulators said the first oral treatment of COVID-19, Pfizer’s Paxrovid. Was approved with Lagebrio. However, these treatments are not intended to be used as an alternative to the COVID-19 vaccine. Health Minister Greg Hunt said new treatments would allow doctors to prescribe to people. “That means you don’t necessarily have to be taken to the hospital … and it strengthens our protection and focuses on people with mild to moderate symptoms but at risk of severe illness. “Mr. Hunt told Canberra reporters. The government has ordered 800,000 courses of treatment, which are expected to arrive in the country within a few weeks. Professor Skerritt said that one of the new treatments is not always more effective in treating COVID than other treatments. “These drugs have been tested with different amounts of COVID at different times, so we can’t say’this is much better now’,” he said. “It’s a bit like the Olympics. I don’t know who is the best athlete until they come head-on.” State and territory leaders meet with Prime Minister Scott Morrison and the Omicron case increases. After that, the students are deciding on an approach to safely return to school. Morrison said how schools use rapid antigen testing to conduct COVID surveillance is a matter of jurisdiction. Access to rapid antigen testing is also on the agenda of the Capitol. The Australian Pharmaceutical Association said inventories are expected to remain sparse until February due to the still lack of rapid testing across the country, putting great pressure on the profession. The Minister of Health said he had asked the Consumer Watchdog to investigate claims by several companies that the federal government had seized rapid tests. “They are lying-that’s why I’m reporting them to the ACCC,” Hunt said. On Thursday, we also see that the number of people aged 5 to 11 who were first vaccinated exceeded 500,000. Meanwhile, Australia has passed a tough milestone of recording 2 million COVID-19 cases since the pandemic began two years ago. It took the country to record one million cases until January 10, but it took only ten days to reach the second one million cases. On Thursday, 30,825 cases and 25 deaths were reported in New South Wales, and an additional 21,996 infections and 15 deaths were reported in Victoria. Nine people died and about 17,000 died in Queensland, while 927 new cases occurred in Tasmania. Reported by AAP

/images/transform/v1/crop/frm/n8uGJwMg95DiH9D4L9ShGa/ae00205b-15c5-4228-a714-ac9aa2a09cdf.jpg/r2_53_1013_624_w1200_h678_fmax.jpg



COVID-19 Vaccine: Australia’s new COVID vaccine, Novavax gets green light from Therapeutic Goods Department | Newcastle Herald

Source link COVID-19 Vaccine: Australia’s new COVID vaccine, Novavax gets green light from Therapeutic Goods Department | Newcastle Herald

Related Articles

Back to top button